Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Dr Saima Begum Istekhar khan
Eligibility
Inclusion criteria
Inclusion criteria: Abdominal Usg findings suggestive of hepatic steatosis and atleat one of the cardiometabolic risk factors,Body Mass Index(BMI) More than or equal to 23kg/m^2, type 2 diabetes or prediabetes, hypertension , dyslipidemia. Patients with symptoms of fatigue, nausea , belching, itching, abdominal pain, heaviness ,distension and burning sensation in abdomen and constipation.
Exclusion criteria
Exclusion criteria: Viral hepatitis. Hepatocellular carcinoma. Pregnancy and lactating woman. Pateints on hepatotoxic drug. alcoholic liver disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Study is Expected to Identify Medovaha sroto dushti as one of the causes of Metabolic Dysfunction-Associated Steatotic liver Disease. A Developed questionnaire for AssesSMENT OF Medovaha srotas dushti hetu.by identifying specific etiological factors associated with MASLD in context of Medovaha Srotas Dushti , appropriate preventive measures and dietary modifications can be recommended, helping to prevent disease progression of steatotic/fatty liver.Timepoint: At baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| By identifying specific etiological factors associated with MASLD in context of Medovaha Srotas Dushti , appropriate preventive measures & dietary modifications can be recommended, helping to prevent disease progression of steatotic/fatty liver.Timepoint: At Baseline | — |
Countries
India
Contacts
Public ContactDr Saima Begum Istekhar Khan
Dr D Y Patil College of Ayurvesd and Reearch Centre Pimpri Pune
Outcome results
None listed